Clinical Trials

NCT03412162 | ACTIVE_NOT_RECRUITING | NA
400 participants

Biology, Identity & Opportunity Study

Study Type:
INTERVENTIONAL
Last Updated:
2026-07-20
Start Date:
2017-12-16
Completion:
2030-12-31
Conditions
  • Stress, Psychological
  • Stress, Emotional
  • Stress, Physiological
Interventions
  • BEHAVIORAL
No Results Yet
NCT02923778 | ACTIVE_NOT_RECRUITING | PHASE2
40 participants

Talimogene Laherparepvec and Radiation Therapy in Treating Patients With Newly Diagnosed Soft Tissue Sarcoma That Can Be Removed by Surgery

Study Type:
INTERVENTIONAL
Last Updated:
2026-07-20
Start Date:
2019-12-31
Completion:
2026-12-29
Conditions
  • Leiomyosarcoma
  • Liposarcoma
  • Sarcoma G2
  • Sarcoma G3
  • Soft Tissue Sarcoma
  • Soft Tissue Sarcoma of the Trunk and Extremities
  • Stage I Soft Tissue Sarcoma AJCC v7
  • Stage II Soft Tissue Sarcoma AJCC v7
  • Undifferentiated Pleomorphic Sarcoma
Interventions
  • PROCEDURE
  • RADIATION
  • BIOLOGICAL
No Results Yet
NCT02359565 | ACTIVE_NOT_RECRUITING | PHASE1
71 participants

Pembrolizumab in Treating Younger Patients With Recurrent, Progressive, or Refractory High-Grade Gliomas, Diffuse Intrinsic Pontine Gliomas, Hypermutated Brain Tumors, Ependymoma or Medulloblastoma

Study Type:
INTERVENTIONAL
Last Updated:
2026-07-20
Start Date:
2015-06-03
Completion:
2026-01-05
Conditions
  • Constitutional Mismatch Repair Deficiency Syndrome
  • Lynch Syndrome
  • Malignant Glioma
  • Recurrent Brain Neoplasm
  • Recurrent Childhood Ependymoma
  • Recurrent Diffuse Intrinsic Pontine Glioma
  • Recurrent Medulloblastoma
  • Refractory Brain Neoplasm
  • Refractory Diffuse Intrinsic Pontine Glioma
  • Refractory Ependymoma
  • Refractory Medulloblastoma
Interventions
  • PROCEDURE
  • BIOLOGICAL
No Results Yet
Previous
Sorted by latest updates
Next
Showing 40 trials per page